Specialty

Magellan Spine Technologies, Inc. announced today receipt of the CE Mark for the Company’s DART™ Disc Annular Repair Technology System. This patented technology is used to seal the access site in the annulus fibrosus following lumbar spine microdiscectomy.

At the recent Charing Cross Symposium in London, Bolton Medical announced the launch of a new and further improved delivery system: RELAY Plus.

NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it has agreed to purchase Cervitech® Inc., a New Jersey based company focused on clinical approval of the PCM® cervical disc system, a motion preserving total disc replacement device.

Minnow Medical, a developer of innovative products to treat artery disease, announced it has received the CE Mark clearing its disposable catheter for marketing in the European Union.

Transoma Medical, Inc. announced the first enrollment and implant in a long-term study to monitor patients who have suffered a cryptogenic stroke (of unknown origin) to determine if atrial fibrillation is present.

Rush University Medical Center is testing a new procedure for regenerating damaged articular cartilage in the knee joint to relieve the pain of osteoarthritis.

Core Essence Orthopaedics, Inc. announced that it has received 510(k) regulatory approval from the Food and Drug Administration for SECURUS™, a novel knotless suture anchor system used in minimally invasive, arthroscopic surgery.

NMT Medical, Inc. today announced that it received Pre-Market Approval from the U.S. Food and Drug Administration enabling commercial sale of the Company’s STARFlex® cardiac septal repair implant in the United States for patients with ventricular septal defects.

In a move to further expand a comprehensive cardiovascular portfolio, Medtronic, Inc. announced today the completion of its acquisition of CoreValve Inc.

Medtronic, Inc. today announced the start of ENGAGE¹, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.

Berlin Heart GmbH announced it has received its first marketing approval in North America, for the EXCOR® Pediatric ventricular assist device.

LDR, a total spine solution company, announced that it received FDA clearance on Feb. 2 to market its ROI-A™ implant as an anterior lumbar interbody fusion (ALIF) device.

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval for its Surgical Ablation Probe with Stabilization Sheath.

Abbott today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in patients with iliac artery disease.

CVRx announced that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function.

Sorin Group and Orange Business Services today announced an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management devices.